Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRAALL-2014
2014-002146-44Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of nelarabine and nilotinib in acute lymphoblastic leukemia (ALL), sponsored by Assistance publique - Hôpitaux de Paris. Started Apr 2015; status: active.
02
Drugs
nelarabinenilotinib
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2014-002146-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002146-44.